相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
Pang-ning Teng et al.
GYNECOLOGIC ONCOLOGY (2015)
Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer
Svetlana Grabauskiene et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
Amy B. Hall et al.
ONCOTARGET (2014)
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Catherine J. Huntoon et al.
CANCER RESEARCH (2013)
Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli
K. Sakamoto et al.
ONCOGENE (2013)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
Regulation of Rev1 by the Fanconi anemia core complex
Hyungjin Kim et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
Jean-Damien Charrier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Philip M. Reaper et al.
NATURE CHEMICAL BIOLOGY (2011)
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia
Gerry P. Crossan et al.
NATURE GENETICS (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
Pia Rantakari et al.
HUMAN MOLECULAR GENETICS (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Human RAD50 Deficiency in a Nijmegen Breakage Syndrome-like Disorder
Regina Waltes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Stephen P. Jackson
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M
Sietske T. Bakker et al.
HUMAN MOLECULAR GENETICS (2009)
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Sarah E. Golding et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation
Michael D. Rainey et al.
CANCER RESEARCH (2008)
Irreversible chromosome damage accumulates rapidly in the absence of ATM kinase activity
Jason S. White et al.
CELL CYCLE (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
ATM sequence variants associate with susceptibility to non-small cell lung cancer
Hushan Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated
Richard D. Kennedy et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling
Thomas Stiff et al.
EMBO JOURNAL (2006)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
TopBP1 activates the ATR-ATRIP complex
A Kumagai et al.
CELL (2006)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival
CJ Marsit et al.
ONCOGENE (2004)
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
I Hickson et al.
CANCER RESEARCH (2004)
The Mre11 complex is required for ATM activation and the G2/M checkpoint
CT Carson et al.
EMBO JOURNAL (2003)
Requirement of the MRN complex for ATM activation by DNA damage
T Uziel et al.
EMBO JOURNAL (2003)
A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome
M O'Driscoll et al.
NATURE GENETICS (2003)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9
Y Yang et al.
BLOOD (2001)
ATR and ATRIP: Partners in checkpoint signaling
D Cortez et al.
SCIENCE (2001)
分享论文
